By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...
The FDA cited concerns about human factors in the use of Aquestive Therapeutics’ Anaphylm sublingual film for anaphylaxis and other type 1 allergic reactions in its complete response letter to the ...
Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results